The company plans to raise ₹808 crore from an initial public offer (IPO). Of the total IPO proceeds, it would issue fresh shares worth ₹627 crore that will be used for expansion of its installed capacity, pruning its debt, and improving working capital, while the remaining is an ‘offer for sale’ by promoters.
SynopsisThe stock of Aether may enjoy a superior earnings multiple compared with the sector average, in the long run, thanks to its market leadership in several products on a global basis, premium pricing, higher earnings growth than its peers, and unique selection of new products to target complex chemistry that provides a high entry barrier. However, in a choppy market, the high asking P/E is more suited for high-risk players.
Aether Industries is a speciality chemicals company whose products are used as critical raw material for drugs used for preventing heart strokes and hypertension. It also makes chemicals that aid in superior image resolution for high-end photography and coatings used in high-end cars.
The company plans to raise ₹808 crore from an initial public offer (IPO). Of the total IPO proceeds, it would issue fresh shares worth ₹627 crore that will be
- FONT SIZE
Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors
Stock analysis. Market Research. Industry Trends on 4000+ Stocks
Clean experience with
Comment & Engage with ET Prime community
Exclusive invites to Virtual Events with Industry Leaders
A trusted team of Journalists & Analysts who can best filter signal from noise